Based on microarray and RT-qPCR analyses of 43 tumor samples, the authors reported significant upregulation of TGF-β2 in high-grade tumors (G3/G4) compared to low-grade gliomas (G2), along with increased expression of TGF-β1 in the microarray dataset [24]. This evidence concerns the gene TGFB1 and central nervous system cancer.